Primary hypothyroidism during therapy with alpha-interferon;Insorgenza di ipotiroidismo primitivo in corso di terapia con alfa-interferone

Recenti Progressi in Medicina

Volumn 87, Issue 7-8, 1996, Pages 342-345

  Saglietti, Giuseppe ^a,b   Ferrari, Vincenzo ^a   Luraschi, Annalisa ^a   Ripamonti, Giorgio ^a   Gioria, Aldo ^a   Fedeli, Paola ^a   Bersi, Mario ^a  

^a Ospedale   (Italy)

^b NONE   (Italy)

Author keywords

autoimmune hypothyroidism; interferon

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; THYROID ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; ETIOLOGY; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; SIDE EFFECT;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; HYPOTHYROIDISM; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED;

EID: 0029737708     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Isaacs A, Lindenmann J. Virus interferences. The interferon. Proc R Soc B 1957; 147: 255-67.
2. Lengyel P. Biochemistry of interferons and their actions. Ann Rev Biochem 1982; 51: 251.
3. Dianzani F. Interferon treatments: how to use an endogenous system as a therapeutic agent. J Interferon Res, special issue 1992; 109 (May).
4. Goldstein D, Laszlo J. Interferon therapy in cancer. Cancer Res 1986; 46: 4315.
5. Mandelli F, Avvisati G, Amadori S, et al. Maintenance treatment with recombinant interferon alpha 2b in patients with multiple myeloma responding to conventional induction chemotherapy. N Engl J Med 1990; 322: 1430-4.
6. Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating MJ, Guttermann JU. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. N Engl J Med 1986; 314: 1065-9.
7. Vugrin D, Hood L, Taylor W, Laszlo. A phase II study of human lymphoblastoid Interferon in patients with advanced renal carcinoma. Cancer Treat Reg 1985; 69: 817-20.
8. Creagan ET, Ahmann DL, Green SJ, et al. Phase II study of low dose recombinant leukocyte. A interferon in disseminated malignant melanoma. J Clin Oncol 1984; 2: 1002-5.
9. Sen GC, Lengyel P. The interferon system. A bird's eye view of its biochemistry. J Biol Chem 1992; 267: 5017.
10. Rager-Zisman B, Bloom BR. Interferons and natural killer cells. Br Med Bull 1985; 41: 22.
11. Hooks JJ, Moutsopoulos HM, Notkins AL. The role of interferon in immediate hypersensitivity and autoimmune disease. Ann NY Acad Sci 1980; 350: 21-32.
12. Burman P, Karlsson FA, Oberg K, Alm G. Autoimmune thyroid disease in interferon treated patients. Lancet 1985; 2: 100-1.
13. Schultz M, Brabant G, Von Zur Muhlen A, Miller R. Induction of autoimmune thyroid disease by treatment with recombinant interferon alpha in patients with chronic NANB hepatitis. Hepatology 1989; 9 (Suppl 1): 223.
14. Burman P, Totterman T, Oberg K, Karlsson A. Thyroid autoimmunity in patients on long term therapy with leukocyte derived interferon. J Clin Endocr Metab 1986; 63: 1086-90.
15. Marcellin P, Pouteau M, Baudin E, et al. Thyroid dysfunction induced by recombinant alpha interferon in patients with chronic hepatitis C: a prospective study. Hepatology 1991; 14: 77.
16. Marcellin P, Pouteau M, Renard P, et al. Sustained hypotiroidism induced by recombinant alpha-interferon in patients with chronic hepatitis C. Gut 1992; 33: 855-6.
17. Tood I, Pujol-Borrell R, Hammond LJ, Bottazzo GF, Feldmann M. Interferon gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985; 61: 265-73.
18. Fentiman IS, Balkwin FR, Thomas BS, Russeu MJ, Tood I, Bottazzo GF. An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. Eur J Cancer Clin Oncol 1988; 24: 1299-303.
19. Orava M, Vihko R. Autoimmune thyroid disease in interferon treated patients. Lancet 1985; 13: 100.
20. Hideki A, Hanafusa T, Kobayashi T, et al. Interferon gamma reduces the thyroid peroxidase content of cultured human thyreocites and inhibits its increase induced by thyreotropin. J Clin Endocr Metab 1992; 74: 1331-5.
21. Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW. Exacerbation of simptoms of autoimmune disease in patients receiving alpha interferon therapy. Cancer 1990; 65: 2237-42.